How to close the gap between seeing a signal and acting on it

‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

No images? Click here

 

NEW WEBINAR

 

Intelligent oversight and orchestration: How mission control is redefining R&D decision-making

Tuesday, October 20, 11:00 AM ET

 
RESERVE YOUR SEAT NOW
 
 

Pharma R&D has invested millions in digitizing clinical operations, yet many portfolio and program decisions still rely on periodic reviews, static dashboards and manual escalation. Despite significant advances in data and analytics, leaders often struggle to answer critical questions quickly and consistently: Which assets should be accelerated, delayed or deprioritized? Which risks require intervention now? How will emerging operational signals impact timelines, costs and probability of success across the portfolio?

As pipelines become more complex and development timelines continue to compress, the gap between seeing a signal and acting on it is emerging as one of the largest barriers to R&D productivity. While organizations have improved visibility, many still lack the ability to systematically translate insights into timely, coordinated decisions.

Join industry experts for a discussion on the future of R&D oversight and why the shift from visibility to next best action is becoming essential. The conversation will explore how mission control combines connected data, scenario simulation and agentic AI to help R&D organizations move beyond monitoring performance to receiving real-time, risk-adjusted recommendations that connect cross-functional signals and surface the most effective actions to take next. Attendees will gain perspectives on how leading organizations are rethinking decision-making, improving operational agility and creating a more proactive approach to managing clinical development.

The session will include:

  • An industry perspective on the evolving R&D decision-making landscape and the barriers to faster, more informed action
  • A deeper look at how next best action capabilities can be embedded within drug development mission control to support decisions such as portfolio prioritization, resource allocation, risk mitigation and intervention before delays become business-critical
  • A live executive demonstration of mission control and next-best-action capabilities in action
 

EXCLUSIVE SPONSOR

ZS
 

MIKE MARTIN

PRINCIPAL
ZS

VISHAL KABRA

PRINCIPAL
ZS

NITIN CHAWLA

PRINCIPAL
ZS

SURANI FERNANDO

HEALTHCARE JOURNALIST, WRITER & PODCAST PRODUCER
RAISING BIOTECH PODCAST
MODERATOR

 
RESERVE YOUR SEAT NOW
 
 

Designed by

Interested in sponsoring your own webinar?
Contact us at cs-webinars-events@endpointsnews.com

Upgrade to a paid subscription.

 
 
  Tweet 
  Share 
  Forward 

Subscriptions/support help@endpoints.news
Advertising/partnerships Ryan McRae

rmcrae@endpoints.news

Endpoints News 2029 Becker Drive, Lawrence, KS 66047 USA

This is a sponsored email for Endpoints News subscribers. You may opt-out of sponsored emails by upgrading to a paid Insider subscription.

 

No longer wish to receive certain emails from Endpoints, including the daily news? You can:
 

  • Update your unsubscribe preferences or
  • Unsubscribe from all communication, including the daily news, using the unsubscribe link below.
Unsubscribe